# A Study of JNJ-95597528 in Participants With Inadequately Controlled Moderate to Severe Asthma

> **NCT07746687** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Janssen Research & Development, LLC** · enrollment: 440 (estimated)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** JNJ-95597528
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07746687
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10-29
- **Primary completion:** 2029-09-11
- **Final completion:** 2030-07-01
- **Target enrollment:** 440 (ESTIMATED)
- **Last updated:** 2026-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07746687

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07746687, "A Study of JNJ-95597528 in Participants With Inadequately Controlled Moderate to Severe Asthma". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07746687. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*